Business Description
Spectral AI Inc
NAICS : 339112
SIC : 3844
ISIN : US84757T1051
Share Class Description:
MDAI: Ordinary Shares - Class ADescription
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.67 | |||||
Equity-to-Asset | -0.31 | |||||
Debt-to-Equity | -2.41 | |||||
Debt-to-EBITDA | -0.93 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -6.38 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate | 10.18 | |||||
Future 3-5Y Total Revenue Growth Rate | 22.24 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.87 | |||||
9-Day RSI | 41.94 | |||||
14-Day RSI | 42.86 | |||||
6-1 Month Momentum % | -5.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.71 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 6.97 | |||||
Days Sales Outstanding | 31.51 | |||||
Days Payable | 86.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -24.68 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 45.12 | |||||
Operating Margin % | -51.84 | |||||
Net Margin % | -89.85 | |||||
FCF Margin % | -69.93 | |||||
ROA % | -154.53 | |||||
ROIC % | -132.07 | |||||
ROC (Joel Greenblatt) % | -1015.65 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.07 | |||||
EV-to-EBIT | -2.52 | |||||
EV-to-EBITDA | -2.68 | |||||
EV-to-Revenue | 1.31 | |||||
EV-to-Forward-Revenue | 1.04 | |||||
EV-to-FCF | -1.88 | |||||
Earnings Yield (Greenblatt) % | -39.68 | |||||
FCF Yield % | -61.29 |